Global Urea Breath Test Systems Market By Product (Urea Breath Test Kits, Urea Breath Test Analyzers), By End-User (Hospitals, Specialized Clinics, Laboratories, Other End-Users), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

A urea breath test is used to detect Helicobacter pylori (H. pylori), a type of bacteria that may infect the stomach and is the leading cause of stomach and duodenal ulcers. Urease is an enzyme produced by Helicobacter pylori that breaks down urea into ammonia and carbon dioxide.

During the test, a urea tablet is swallowed, and the amount of carbon dioxide exhaled is measured. This shows that H. pylori is present in the stomach. If the urea breath test is positive and the isotope is identified in the breath, the stomach is infected with H. pylori. If the isotope is not identified in the breath, the infection test results are negative.

The UBT is currently considered as one of the most essential and reliable non-invasive procedures to diagnose H pylori infection. The test is straightforward, safe when 13C is used, easy to repeat, and extremely accurate, with only a few precautions required to obtain reliable results.

Request Covid - 19 Impact

It is especially useful for epidemiological research in children and adults as well as in any clinical situations where endoscopy is not necessary strictly, and to determine whether eradication treatments are working. The ability to use a lower urea dose in capsules, thereby skipping a meal, as well as shorter than usual sample times, will undoubtedly promote an interdisciplinary approach.

Detailed Segmentation

The global urea breath test systems market is segmented on the basis of - Product Type, End-User, and Region:

Based on Product Type

• Urea Breath Test Kits
• Urea Breath Test Analyzers

Based on End-User

• Hospitals
• Specialized Clinics
• Laboratories
• Other End-Users

Based on Regions

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics

When compared to other methods used to detect H. pylori infection, the serologic test is significantly less expensive. Many non-invasive procedures, such as the Stool Antigen Test (SAT), the Urea Breath Test (UBT), etc., are recommended over invasive biopsy approaches that need endoscopy. These tests are well-suited to large-scale testing and UBT is used to ensure accurate results. Because UBT involves the entire stomach, this approach is free of sampling mistakes.

The urea breath test is commonly used to diagnose current infection and confirm that H. pylori has been successfully eliminated after therapy. The American Gastroenterological Association (AGA) recommends stool antigen testing and urea breath testing as non-invasive active testing procedures. As a result, the benefits of quick diagnosis and the availability of low-cost testing kits will drive widespread use of non-invasive testing procedures.

Point-of-Care Testing (POCT) provides accurate results in a short period of time at a low cost. In the market for urea breath test systems, companies are focusing on producing sophisticated diagnostic kits. The enhancement of new products for helicobacter pylori tests will provide growth opportunities for this industry.

Individuals with multiple health conditions are usually more vulnerable to infections and require early detection of diseases. Greater accessibility of point-of-care testing and easy availability of numerous invasive and non-invasive devices will positively impact business expansion.

Key Players:

• Thermo Fisher Scientific
• Sercon Ltd.
• Bio-Rad Laboratories Inc.
• Shenzhen Zhonghe Headway Bio-Sci & Tech Co Ltd.
• Kibion AB
• Beijing Richen-Force Science & Technology Co Ltd.
• Exalenz Bioscience Ltd.
• AdvaCare Pharma
• Kizlon Inc.
• Meridian Bioscience Inc.
• Other Key Players

For the Urea Breath Test Systems Market research study, the following years have been considered to estimate the market size: